Liaquat University of Medical & Health Sciences (Liaquat University of Medical & Health Sciences)

概览

关联

43

项与 Liaquat University of Medical & Health Sciences 相关的临床试验

NCT06227858

/ RecruitingN/AIIT

Investigation of the Psychological and Physiological Effects of a Standardised Saffron Extract Supplementation on Symptoms Associated to Perimenopause in Healthy Older Women: A Randomised Double-blind, Placebo-Controlled, Parallel-group Clinical Trial

The aim of the present study is to assess the effects of a normalised saffron extract supplementation, which is an extract of the flower Crocus sativus, on perimenopausal symptoms.

开始日期2025-08-20

申办/合作机构

Liaquat University of Medical & Health Sciences

[+2]

NCT06983223

/ RecruitingN/AIIT

Oral Sucrosomial® Vitamin B12 in the Management of B12 Deficiency Among Metformin-Treated Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the effectiveness of Sucrosomial® Vitamin B12 supplementation in the management of vitamin B12 deficiency among metformin-treated Type 2 Diabetes Mellitus (T2DM) patients. The study will compare the impact of daily Sucrosomial® B12 (1,000 mcg) versus placebo on serum vitamin B12 levels, Holo-Transcobalamin II (HoloTCII), and Transcobalamin I (TCI) levels over a 4-week period. Secondary outcomes include assessment of safety, tolerability, and glycemic control (HbA1c). Fifty participants will be randomly assigned to either the Sucrosomial® B12 or placebo group.

开始日期2025-08-15

申办/合作机构

Liaquat University of Medical & Health Sciences

NCT06982365

/ Active, not recruitingN/AIIT

Study to Investigate the Potential Health Benefits of Grapes Seeds Extract Supplementation in the Management of Elevated Blood Pressure or Stage 1 Hypertension: A Pragmatic Randomized, Double-blind Placebo Controlled Trial

This study is a pragmatic, randomized, double-blind, placebo-controlled trial aimed at evaluating the potential health benefits of Enovita® (standardized grape seed extract) supplementation in adults with elevated blood pressure or Stage 1 hypertension. The primary objective is to assess the impact of Enovita® on systolic and diastolic blood pressure over 8 weeks. Secondary outcomes include changes in mood, emotional well-being, perceived stress, lipid profile, and systemic inflammation. The study will also monitor the safety and tolerability of Enovita®.

开始日期2025-08-01

申办/合作机构

Liaquat University of Medical & Health Sciences

100 项与 Liaquat University of Medical & Health Sciences 相关的临床结果

登录后查看更多信息

0 项与 Liaquat University of Medical & Health Sciences 相关的专利（医药）

登录后查看更多信息

1,022

项与 Liaquat University of Medical & Health Sciences 相关的文献（医药）

2026-01-01·ARCHIVES OF MEDICAL RESEARCH

Biochemical Profile of Recovered Individuals With Mild COVID-19: A Cross-Sectional View at Two Different Time Points

Article

作者: Abbas, Uzair ; Babar, Nisha ; Nasrumminallah, Maryam ; Khalid, Muhib Ullah ; Mukhtiar, Sawairah ; Hafeez, Sumbal ; Ashraf, Shizrah ; Hussain, Niaz ; Kumar, Pershad ; Ahmed, Ishfaque ; Khan, Muhammad Shahid

AIM:

This study was designed to cross-sectionally evaluate the frequency of long COVID-19, along with their hematological and biochemical parameters in survivors of mild COVID-19 after 6-15 months of acute infection.

METHODS:

We recruited 75 age-matched healthy controls (HC) and 150 individuals who had recovered from mild cases of COVID-19. The recovered individuals were grouped according to the time elapsed since acute infection: 6-10 month (CoV_A) and >10-15 month of recovery (CoV_B). A brief clinical history was taken and detailed hematological and biochemical blood parameters were measured.

RESULTS:

In our study, 64% of individuals had symptoms of long COVID. There were differential symptoms and presenting complaints associated with time since acute infection. The recovered group had significantly different hemoglobin concentration, red blood cell (RBC) count, white blood cell (WBC) count, lymphocyte, interleukin-6 (IL-6), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and vitamin D3 levels, compared with the healthy controls (p<0.05). Differences were also found between the 6-10 months and the >10-15 month recovery groups (p<0.05).

CONCLUSION:

Differential biochemical markers related to the time elapsed since acute infection show a different metabolic and biochemical status of the host at different time points after infection. Moreover, the pathophysiological pathways involved in these dysregulated biochemical markers should also be studied in relation to the long term impact of COVID-19 infection.

2026-01-01·INTERNATIONAL JOURNAL OF CARDIOLOGY

Letter to the editor: Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study

Letter

作者: Das, Ravi ; Lohana, Sunita ; Lohano, Govinda ; Lohano, Gaaitri

2025-12-01·INTERNATIONAL JOURNAL OF CARDIOLOGY

A critique on the association between non-classical monocytes and HFpEF pathophysiology

Letter

作者: Sheikh, Hafsa ; Atif, Muhammad Mudasir ; Jawad, Muhammad

100 项与 Liaquat University of Medical & Health Sciences 相关的药物交易

登录后查看更多信息

100 项与 Liaquat University of Medical & Health Sciences 相关的转化医学

登录后查看更多信息